Health Care & Life Sciences » Pharmaceuticals | Sawai Pharmaceutical Co. Ltd.

Sawai Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
18,989
20,297
23,091
22,757
20,251
25,666
Depreciation, Depletion & Amortization
4,989
5,863
7,044
8,520
14,239
16,280
Other Funds
18
18
293
303
23,389
2,654
Funds from Operations
18,797
18,743
23,983
25,276
34,527
39,291
Changes in Working Capital
5,375
6,631
4,008
2,006
6,055
3,632
Net Operating Cash Flow
13,422
12,112
19,975
23,270
28,472
42,923
Capital Expenditures
7,352
13,250
17,775
18,838
16,806
Purchase/Sale of Investments
991
799
52
-
-
Net Investing Cash Flow
8,283
14,123
22,937
18,827
127,900
Cash Dividends Paid - Total
3,001
3,674
4,050
4,793
4,793
Issuance/Reduction of Debt, Net
2,610
2,548
17,354
1,665
57,393
Net Financing Cash Flow
178
921
13,473
6,761
108,597
Net Change in Cash
4,961
2,932
10,492
2,325
9,221
Free Cash Flow
6,401
184
2,522
7,737
18,153
Net Assets from Acquisitions
16
-
5,181
-
111,195
Other Sources
76
-
-
12
102
Change in Capital Stock
231
223
462
-
32,608
Exchange Rate Effect
-
-
19
7
52
Other Uses
-
74
33
-
-

About Sawai Pharmaceutical Co.

View Profile
Address
5-2-30 Miyahara
Osaka Osaka 532
Japan
Employees -
Website http://www.sawai.co.jp
Updated 07/08/2019
Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan.